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Virtual reality technology can provide a wide range of sensory stimuli to generate conflicts of 
varying degrees of complexity in a safe environment.
Objective: To verify the effect of a virtual reality-based balance rehabilitation program for patients 
with Menière’s disease.
Method: This observational clinical study included 44 patients aged between 18 and 60 years 
diagnosed with Menière’s disease submitted to a controlled randomized therapeutic intervention. 
The case and control groups took betahistine and followed a diet. Case group subjects underwent 
12 rehabilitation sessions with virtual reality stimuli in a Balance Rehabilitation Unit (BRUTM). Patients 
were assessed based on DHI scores, the dizziness visual analogue scale, and underwent posturography 
with virtual reality before and after the intervention.
Results: After the intervention, the case group showed significantly lower scores in DHI (p < 0.001) 
and in the dizziness visual analog scale (p = 0.012), and had significantly greater limit of stability 
areas (p = 0.016) than controls.
Conclusion: Virtual reality-based balance rehabilitation effectively improved dizziness, quality of 
life, and limit of stability of patients with Menière’s disease.
ORIGINAL ARTICLE
Braz J Otorhinolaryngol.
2013;79(3):366-74. BJORL
Keywords:
dizziness;
Ménière disease;
rehabilitation.
.org
DOI: 10.5935/1808-8694.20130064
367
Brazilian Journal of otorhinolaryngology 79 (3) May/June 2013
http://www.bjorl.org  /  e-mail: revista@aborlccf.org.br
INTRODUCTION
Ménière’s disease is characterized by tinnitus, 
vertigo, and hearing loss in paroxysmal episodes wi-
thout the involvement of the central nervous system. The 
condition was described by Prosper Ménière in 18611. 
Endolymphatic hydrops is believed to be the pathophy-
siological basis of the disease. However, the specificity 
of the association between evidences of endolymphatic 
hydrops and clinical manifestations of the disease does 
not appear to be absolute2.
Ménière’s disease has been described as recurring 
vertigo episodes lasting for a minimum of 20 minutes 
accompanied by nausea and vomiting, spontaneous ho-
rizontal rotational nystagmus, hearing loss, aural fullness, 
and tinnitus. Four levels of certainty have been attributed 
to the diagnosis of Ménière’s: certain, when confirmation 
is available through pathology testing; definite, when the 
patient has had two or more spontaneous episodes of ver-
tigo lasting for at least 20 minutes, sensorineural hearing 
loss, tinnitus or sensation of aural fullness in the involved 
ear; probable, when the patient has had one episode of 
vertigo, sensorineural hearing loss, tinnitus or aural full-
ness in the affected ear; and possible, when the patient 
has had recurrent episodic vertigo without documented 
hearing loss, or fluctuating or stable sensorineural hearing 
loss with imbalance without recurrent episodic vertigo3.
Vestibular rehabilitation has been proposed to 
improve the quality of life of individuals experiencing dizzy 
spells and body imbalance. It is based in a program of 
exercises for the eyes, head, and body, involving specific 
physical maneuvers associated with changes of life style 
e clarification on imbalance. Vestibular rehabilitation is a 
physiological, innocuous, coherent therapy that acts on the 
vestibular system to stimulate central nervous system plasti-
city, promote the reinstatement of body balance, accelerate 
and stimulate the natural mechanisms of compensation, 
adaptation, and acclimatization4.
The exercises aim to modify the subject’s postural 
control system by exposing the patient to different visual 
environments along with congruent and conflicting stimuli; 
mitigate dizziness and body imbalance; enhance the sta-
bility of the patient’s gaze and improve his/her postural 
control, competence, and well-being while performing 
activities of daily living5.
There is no consensus on the use of body balance 
exercise programs in patients with Ménière’s, given the 
fluctuating nature of the disease. Some authors believe that 
the ideal candidate for body balance rehabilitation is the 
patient with stable Ménière’s disease6,7; others recommend 
exercises in two situations: 1) patients who underwent 
destructive therapies such as vestibular neurectomy or 
labyrinthectomy to accelerate the recovery of balance and 
postural stability8; and 2) patients with body imbalance 
persisting without the other symptoms of Ménière’s9.
Virtual reality enables patients to dive into a world 
of illusion. The perception of the environment is modi-
fied by artificial stimuli, generating sensory conflict and 
altering the gain of the vestibulo-ocular reflex10. Repetitive 
movements of images on the retina produced by virtual 
reality devices designed to control visual stimuli may 
induce vestibular response adaptation11 and adjust the 
vestibulo-ocular and vestibulospinal reflexes involved in 
postural control and body balance strategies12-14.
Virtual reality technology enables therapists to 
offer patients a wide range of highly specific stimuli and 
sensory conflicts of varying degrees of complexity in a 
safe environment15.
Few studies have been published on the use 
of virtual reality in vestibular rehabilitation. Patients 
with Ménière’s disease, when compared to healthy 
subjects, presented significantly greater areas of cen-
ter of pressure (CoP) and higher oscillation rates in 
Balance Rehabilitation Unit (BRUTM)16 posturography, 
indicating the usefulness of this procedure in patient 
assessment. Patients with central vestibular syndromes13 
and elderly subjects suffering from imbalance and risk 
of falls17 showed improved posturography parameters 
after treatment with virtual reality. However, stability 
limit areas and oscillation rates were similar before and 
after 12 sessions of rehabilitation with virtual reality in 
a pilot study in which ten subjects with Ménière’s were 
treated twice per week18.
Virtual reality may be an important tool in the tre-
atment of subjects with Ménière’s - a disease with signifi-
cant incidence rates, ranging from 7.7 to 157 per 100,000 
people19,20. The lack of case-control studies on the topic 
motivated the verification of the efficacy of this instrument 
in the rehabilitation of the vestibular systems of patients 
with the disease.
This study aimed to verify the effect of a body 
balance program based on stimuli produced through virtual 
reality in patients with Ménière’s disease.
METHOD
This randomized controlled cohort study was carried 
out in the Vestibular Rehabilitation Section of the Otology 
and Otoneurology Course administered in the Department 
of Otorhinolaryngology and Head and Neck Surgery of 
the Federal University of São Paulo - Paulista Medical 
School (UNIFESP-EPM) from 2008 to 2011. The study was 
approved by the institution’s Research Ethics Committee 
and given permit 1142/08.
All patients included in the study were provided 
with clarification and asked to give informed consent.
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Patients of both genders, aged between 18 and 60 
years, diagnosed with definite3 Ménière’s disease by an 
ENT, and with complaints of dizziness in the disease’s 
intercritical periods were enrolled in the study.
Study participants were taking betahistine (one 
24 mg dose every 12 hours) and had been under ENT 
follow-up. In dietary terms, they were asked to have subs-
tantial breakfasts, light lunches, and even lighter dinners; 
avoid intervals greater than three hours between meals; 
refrain from having refined sugar, coffee, or alcohol; and 
refrain from smoking.
Patients diagnosed with bouts of the disease by 
the ENT physician immediately before the beginning of 
the study were excluded, as were subjects with rheumatic 
diseases, uncontrolled high blood pressure, heart disease, 
severe visual involvement or decompensated involvement 
despite contact lenses, orthopedic disorders resulting in 
motion limitation or use of lower limb prostheses, psychia-
tric disorders, individuals submitted to stem cell transplant, 
patients unable to comprehend and obey simple verbal 
commands or stand independently in an orthostatic posi-
tion, subjects who drank alcohol 24 hours before the tests, 
patients submitted to balance rehabilitation programs in 
the six months prior to the study, subjects who missed 
three consecutive body balance rehabilitation sessions, 
and those who failed to follow the orientations proposed 
by the authors of the study.
The otoneurological assessment of the enrolled 
patients included interviews, the Dizziness Handicap In-
ventory (DHI) to assess quality of life, the analog dizziness 
scale, ENT examination, pure-tone audiometry, speech in-
telligibility testing, impedance testing, functional vestibular 
examination, and posturography with virtual reality in the 
Balance Rehabilitation Unit (BRUTM). DHI, dizziness analog 
scale, and posturography tests were performed before and 
after the intervention.
The DHI’s21 Brazilian Portuguese version22 was 
used to evaluate the self-perceived incapacitating effects 
of dizziness before and after the completion of vestibular 
rehabilitation with virtual reality. Relevant improvements 
were noted when the difference between the DHI scores 
before and after the intervention was greater than 18 
points21. Self-perceived dizziness in DHI score analysis 
was categorized as mild (scores between zero and 30), 
moderate (31 to 60), and severe (61 to 100)23.
The dizziness analog scale24 was used to verify 
symptom intensity before and after the intervention. Sco-
res may range between zero, reflecting the lowest level 
of dizziness, and ten, in reference to the highest levels 
of dizziness.
BRUTM25 was used to assess and rehabilitate patients 
with dizziness and associated symptoms by providing them 
with visual stimuli projected in virtual reality goggles. The 
equipment includes a computer with the test’s program, 
a safety metal frame, protection support with straps and 
belts, a force platform measuring 40 x 40 cm, virtual rea-
lity goggles, an accelerometer and foam cushions. Three 
modules were included: posturography, body balance 
rehabilitation, and postural training games (PTG). The 
equipment was set up in a silent room of approximately 
six square meters with dim lighting26.
The BRUTM posturography module provides infor-
mation on the position of the patient’s center of pressure 
by measuring the stability limit area, CoP area, body oscilla-
tion rate in ten sensory conditions with the subject in an 
orthostatic position: 1) with open eyes; 2) with eyes closed; 
3) with closed eyes on a compliant surface; 4) saccadic 
stimulation; 5) optokinetic stimulation in the horizontal 
direction from left to right; 6) optokinetic stimulation in 
the horizontal direction from right to left; 7) optokinetic 
stimulation in the vertical direction looking up and down; 
8) optokinetic stimulation in the vertical direction looking 
down and up; 9) optokinetic stimulation in the horizontal 
direction associated with slow steady rotation of the head; 
10) optokinetic stimulation in the vertical direction asso-
ciated with slow steady flexion and extension movements 
of the neck25.
In order to assess each of the ten sensory conditions, 
patients were instructed to stand in an orthostatic position 
without moving their upper limbs, heels, or feet for 60 
seconds. They were allowed to wear their usual corrective 
lenses. A foam cushion of medium density was used in the 
third test condition. Virtual reality goggles were used from 
the fourth to the tenth condition. Patients were allowed to 
rest during the procedure as needed. Patients wore safety 
straps and belts and the examiner stood close to them to 
prevent the occurrence of falls during the tests.
The program generated reports containing data on 
stability limit areas, CoP areas (95% confidence ellipse), 
and oscillation rates in the ten test conditions. The 95% 
confidence ellipse was defined as the area in which 95% 
of the center of pressure points were captured during the 
test. Oscillation rates were calculated by the total distance 
divided by the 60 seconds of the test’s duration25.
The 44 patients diagnosed with unilateral or bilateral 
definite Ménière’s disease were divided into case and control 
groups according to a table with uniformly distributed 
random numbers produced by a computer program.
The randomization process assigned 23 patients 
to the case group and 21 to the control group. Unilateral 
disease was seen in 22 of the 23 patients in the case group 
and in 21 controls. Seven patients in the case group had 
unilateral vestibular hypofunction; one had directional 
preponderance nystagmus; fourteen had normal vestibular 
function; and one never completed the tests due to intense 
neurovegetative symptoms Eight patients in the control 
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group had unilateral vestibular hypofunction, and 13 had 
normal vestibular function.
Subjects in the control group were given dietary 
recommendations and prescribed 48 mg/day of betahistine 
(one 24 mg dose every 12 hours). In addition to a similar 
diet and drug therapy, case group individuals performed 
stimulus-enriched exercises on the BRUTM. All patients 
were evaluated as soon as a diagnosis of definite Ménière’s 
disease was rendered by an ENT physician. Case group 
subjects were reassessed immediately after the end of the 
intervention, while controls were seen six weeks after 
treatment.
Body balance rehabilitation exercises were perfor-
med at the clinic twice a week with each patient, adding 
to a total of 12 sessions. Each session lasted 45 minutes 
and was planned based on the sensory conditions and 
altered postural parameters seen in the posturography of 
each individual.
The balance rehabilitation module in the BRUTM 
was made up of a virtual image emitter and 3D goggles 
to create situations that triggered dizzy spells or vertigo 
episodes or aided in the compensation of vestibular 
disorders17. Body balance rehabilitation included visual 
and somatosensory stimuli and the PTGTM module in the 
BRUTM, in three interactive training games on postural 
control, stability limit, and muscle coordination covering 
various motor tasks in varying degrees of difficulty. All 
patients were exposed to foveal (smooth pursuit and 
saccades), retinal (bars, tunnel, and optokinetic train) and 
sensory integration (vestibulo-ocular reflex, suppression 
of the vestibulo-ocular reflex, vestibular optokinetic re-
flex) visual stimuli. Patient skill level and evolution aided 
in the setting up of the visual stimuli in terms of latency, 
duration, frequency, motion, and depth, in addition to 
serving as input on the progression of somatosensory 
stimuli and changes such as the surface patients had to 
stand on during the tests, from firm pads to foam pads 
of varying density; walking on the spot on a firm and a 
compliant surface; and bouncing on a swiss ball. Postural 
control improvements were observed when significant 
increases on stability limit values and significant reduc-
tions on CoP area and BRUTM oscillation rates were seen 
after the intervention.
Patients were informed of all treatment phases and 
of the occurrence of dizzy spells during the exercises, par-
ticularly in the early sessions. They were also made aware 
of the importance of complying with the exercise regimen.
The evaluations and the rehabilitation program were 
carried out by the head researcher. After the intervention, 
the patients were referred to an ENT physician for advice 
on the continuation of the treatment.
Results were specified, treated, and submitted to 
statistical analysis on software program SPSS (Statistical 
Package for Social Sciences) version 19.0. A level of 
significance of 5% (α = 0.05%) was adopted. In the descrip-
tion of the sample, categorical variables were characterized 
in terms of frequencies and their respective percentages, 
while scalar variables were presented in the form of the 
following frequency calculations (n): mean values, stan-
dard deviations, minimum and maximum values. Compa-
risons between case and control groups were performed 
using Fisher’s exact test for categorical variables, and 
Mann-Whitney’s test to look into the interdependences 
between sample elements of a scalar nature. In-group 
comparisons before and after intervention were carried 
out using Wilcoxon’s test.
RESULTS
Table 1 shows the distribution of the 44 patients 
diagnosed with definite Ménière’s according to age, 
gender, and duration, periodicity and time since the onset 
of dizzy spells. No statistically significant differences were 
found between the groups in terms of age, gender, and 
duration, periodicity or time since onset of dizzy spells.
Table 2 presents comparisons including DHI scores, 
dizziness analog scale scores, and stability limit areas 
before and after the intervention, featuring both in-group 
and between group analyses. The comparison of case 
and control groups before the intervention failed to reveal 
significant differences on DHI scores, dizziness analog 
scale scores, or stability limit areas. After the intervention, 
DHI and dizziness analog scale scores were significantly 
lower, whereas stability limit areas were significantly larger 
among case group subjects. Among controls, the dizziness 
analog scale had significantly lower scores.
Table 3 draws comparisons of CoP areas seen in 
BRUTM posturography before and after the intervention 
between case group subjects, controls, and both groups. 
When case and control groups were considered, the com-
parison between the values for CoP area in the ten tested 
sensory conditions after the intervention failed to yield 
significant differences. After the intervention, case group 
subject CoP areas in the firm surface with eyes closed, 
and compliant surface with eyes closed conditions were 
significantly smaller. No significant differences were seen 
among controls for CoP area in the ten tested sensory 
conditions.
Table 4 displays a comparison of the oscillation 
rates in BRUTM posturography before and after the inter-
vention between case group subjects, controls, and both 
groups. No statistically significant differences were seen 
in the comparison of oscillation rates in the ten tested 
sensory conditions between case and control groups 
before and after intervention. After the intervention, case 
group subjects showed significantly lower oscillation rates 
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Table 1. Demographic data and clinical characteristics of the patients in the case and control groups before the intervention.
Variable Case group (n = 23)
Control group 
(n = 21) p
Mean age (minimum-maximum) 47.65 (20-60) 47.90 (19-60) 0.869a
Gender (male/female), n (%) 9 (39.10)/14 (60.90) 7 (33.30)/14 (66.70) 0.761b
Duration of dizzy spells, n (%)
Days 9 (39.10) 7 (33.33)
0.709b
Hours 8 (34.80) 7 (33.33)
Minutes 5 (21.70) 4 (19.01)
Seconds 1 (4.30) 3 (14.33)
Periodicity of dizzy spells, n (%)
Sporadic 5 (21.70) 12 (57.10)
0.087b
Monthly 4 (17.40) 1 (4.80)
Weekly 8 (34.80) 4 (19.00)
Daily 6 (26.10) 4 (19.00)
Time since onset of dizzy spells, n (%)
3 to 6 months 1 (4.30) 2 (9.50)
0.108b
7 to 11 months 1 (4.30) 1 (4.80)
1 to 2 years 4 (17.40) 6 (28.60)
2 to 4 years 5 (21.70) 0 (0.00)
More than 5 years 12 (52.20) 12 (57.10)
a Mann-Whitney test; b Fisher’s exact test.
Table 2. Comparison between case and control groups before and after the intervention: Dizziness Handicap Inventory, dizziness 
analog scale, and stability limit area.
Case Group Control Group
Tests
Before 
Mean/SD 
(min-max)
After 
Mean/SD 
(min-max)
p1
Before 
Mean/SD 
(min-max)
After 
Mean/SD 
(min-max)
p1 p2 p3
DHI (total) 57.57/21.27 (12.00-94.00)
22.87/22.07 
(0.00-72.00) < 0.001*
52.67/21.39 
(18.00-86.00)
48.38/22.37 
(8.00-86.00) 0.092 0.391 < 0.001*
DHI (physical) 17.04/7.26 (2.00-28.00)
6.61/6.91 
(0.00-24.00) < 0.001*
15.62/6.25 
(4.00-32.00)
13.33/7.98 
(0.00-32.00) 0.075 0.24 0.003*
DHI (functional) 22.78/10.00 (4.00-40.00)
9.48/8.64 
(0.00-32.00) < 0.001*
18.67/9.11 
(6.00-40.00)
17.33/8.45 
(2.00-28.00) 0.274 0.131 0.004*
DHI (emotional) 17.91/8.64 (0.00-32.00)
6.78/8.20 
(0.00-26.00) < 0.001*
18.38/8.76 
(4.00-32.00)
17.33/9.81 
(0.00-32.00) 0.447 0.962 0.001*
Dizziness analog scale 7.17/2.06 (3.00-10.00)
2.57/2.41 
(0.00-7.00) < 0.001*
7.81 / 2.16 
(4.00-10.00)
5.43/4.58 
(1.00-22.00) 0.009* 0.283 0.012*
Stability limit 222.22/66.16 (70.00-365.00)
236.22/62.41 
(70.00-373.00) < 0.001*
185.24/52.85 
(88.00-307.00
190.10/60.86 
(78.00-286.00) 0.566 0.307 0.016*
1 Wilcoxon test; 2,3 Mann-Whitney test; DHI: Dizziness Handicap Inventory; SD: Standard deviation; Min: Minimum value; Max: Maximum value; 
p1: In-group comparison; p2: Comparison between groups before intervention; p3: Comparison between groups after intervention; * Statistically 
significant difference.
in the compliant surface with eyes closed condition and 
significantly higher oscillation rates in conditions of sacca-
de stimulation and optokinetic stimulation in the vertical 
direction. Oscillation rates were not significantly different 
between controls in the ten tested sensory conditions.
DISCUSSION
This study looked into the effects of vestibular reha-
bilitation using virtual reality on patients with Ménière’s 
disease. The 21 subjects in the control group were given 
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Table 3. In-group comparisons of center of pressure areas (cm2) before and after intervention.
Case Group Control Group
Conditions Before Mean/SD (min-max)
After Mean/SD 
(min-max) p
1 Before Mean/SD 
(min-max)
After Mean/SD 
(min-max) p
1 p2 p3
FS/open eyes 4.62/7.68 (0.15-33.65)
3.16/4.08 
(0.44-19.04) 0.362
5.04/12.05 
(0.33-56.85)
2.67/4.96 
(0.71-23.86) 0.095 0.851 0.496
FS/eyes closed 5.50/8.89 (0.21-38.93)
2.84/313 
(0.18-12.16) 0.026*
4.53/9.75 
(0.94-1.27)
4.69/10.06 
(0.21-47.70) 0.211 0.359 0.597
CS/eyes closed 13.98/19.76 (1.63-95.37)
7.92/5.71 
(0.99-25.59) 0.042*
13.00/14.95 
(2.04-53.59)
12.72/20.20 
(1.63-95.43) 0.664 0.888 0.842
FS/saccades 1.74/1.44 (0.19-4.46)
2.07/1.56 
(0.15-7.30) 0.574
2.33/3.76 
(0.27-18.18)
3.10/7.78 
(0.26-14.78) 0.889 0.706 0.307
FS/optokinetic, right 2.62/2.82  (0.28-10.70)
3.10/3.98 
(0.26-14.78) 0.784
4.48/10.40 
(0.34-47.94)
6.97/20.72 
(028-96.35) 0.414 0.751 0.991
FS/optokinetic, left 4.93/8.07 (0.11-26.18)
2.80/3.26 
(0.09-13.52) 0.171
5.59/15.78 
(0.26-73.21)
6.07/16.09 
(0.21-74.96) 0.052 0.751 0.751
FS/optokinetic, down 2.80/2.84 (0.15-11.09)
2.56/3.28 
(0.11-16.13) 0.475
3.69/7.08 
(0.23-33.15)
5.75/15.76 
(0.18-73.32) 0.931 0.953 0.916
FS/optokinetic, up 4.16/5.96 (0.12-26.20)
3.35/5.66 
(0.12-24.23) 0.386
4.38/7.83 
(0.33-34.69)
4.86/11.85 
(0.12-24.23) 0.728 0.897 0.605
FS/optokinetic, horizontal 4.81/6.97 (0.69-33.70)
3.43/5.70 
(0.42-28.91) 0.200
4.84/6.68 
(0.45-28.74)
5.62/12.71 
(069-60.39) 0.689 0.796 0.459
FS/optokinetic, vertical 4.14/6.52 (0.76-32.11)
3.24/4.02 
(0.52-20.21) 0.922
4.10/5.22 
(0.53-24.46)
5.44/12.07 
(0.64-57.57) 0.768 0.597 0.445
1 Wilcoxon test; 2,3 Mann-Whitney test; FS: Firm surface; CS: Compliant surface; SD: Standard deviation; Min: Minimum value; Max: Maximum value; 
p1: In-group comparison; p2: Comparison between groups before intervention; p3: Comparison between groups after intervention; * Statistically 
significant difference.
Table 4. Comparison between case and control groups before and after intervention; oscillation rates (cm/s2).
Case Group Control Group
Conditions Before Mean/SD (min-max)
After Mean/SD 
(min-max) p
1 Before Mean/
SD (min-max)
After Mean/SD 
(min-max) p
1 p2 p3
FS/open eyes 0.85/0.52 (0.39-2.88)
0.84/0.57 
(0.43-3.16) 0.976
0.92/1.00 
(0.36-4.42)
0.92/0.98 
(0.39-5.06) 0.289 0.431 > 0.999
FS/eyes closed 1.11/0.70 (0.45-3.75)
1.02/0.70 
(0.39-3.69) 0.173
1.16/1.05 
(0.44-4.99)
1.39-1.83 
(0.42-9.07) 0.144 0.488 0.526
CS/eyes closed 2.68/1.69 (1.33-9.69)
2.22/1.06 
(0.95-5.23) 0.021*
2.60/1.36 
(1.23-9.69)
2.61/1.68 
(1.00-7.90) 0.917 0.888 0.445
FS/saccades 0.95/0.56 (0.47-3.26)
1.09/0.59 
(0.45-3.10) 0.012*
0.94/0.50 
(0.49-2.87)
1.16/1.36 
(0.46-7.01) 0.525 0.832 0.589
FS/optokinetic, right 0.93/0.32 (0.48-1.73)
1.14/1.04 
(0.44-5.50) 0.773
1.08/1.20 
(0.51-6.24)
1.43/2.55 
(0.52-12.48) 0.104 0.438 0.934
FS/optokinetic, left 1.04/0.57 (0.41-3.07)
1.06/0.62 
(0.40-3.02) 0.910
1.00/0.86 
(0.37-4.62)
1.47/2.76 
(0.48-13.49) 0.211 0.347 0.944
FS/optokinetic, down 0.93/0.44 (0.39-2.46)
1.04/0.62 
(0.41-2.96) 0.294
0.96/0.71 
(0.38-3.93)
1.35/2.28 
(0.42-11.23) 0.273 0.630 0.934
FS/optokinetic, up 1.04/0.44 (0.37-2.12)
1.12/0.64 
(0.46-3.10) 0.495
1.07/0.97 
(0.48-5.13)
1.29/1.88 
(0.37-9.38) 0.543 0.347 0.488
FS/optokinetic, horizontal 1.34/0.66 (0.69-3.87)
1.67/1.88 
(0.76-10.00) 0.412
1.38/0.94 
(0.59-4.90)
1.69/2.36 
(0.56-11.80) 0.931 0.638 0.597
FS/optokinetic, vertical 1.43/0.70 (0.78-3.54)
1.77/1.42 
(0.89-7.84) 0.039*
1.52/0.98 
(0.81-5.30)
1.83/2.54 
(0.42-12.68) 0.903 0.733 0.209
1 Wilcoxon test; 2,3 Mann-Whitney test; FS: Firm surface; CS: Compliant surface; SD: Standard deviation; Min: Minimum value; Max: Maximum value; 
p1: In-group comparison; p2: Comparison between groups before intervention; p3: Comparison between groups after intervention; * Statistically 
significant difference.
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dietary recommendations and prescribed 48 mg/day of 
betahistine (one 24-mg dose every 12 hours), while the 23 
individuals in the case group, in addition to similar diets 
and drug therapy, were asked to perform exercises with 
visual, proprioceptive, and vestibular stimulation on the 
BRUTM. We were unable to find other studies in the litera-
ture with the same therapeutic design or in which results 
had been compared against a control group.
In the initial assessment before the intervention, 
patients in the case and control groups were similar in 
terms of gender, age, and duration, periodicity, and time 
since the onset of of dizzy spells; DHI scores; dizziness 
analog scale scores; vestibular examination findings; limits 
of stability; CoP area and oscillation rates in all BRUTM 
posturography conditions, indicating the sample was ho-
mogeneous. DHI indicated moderate impact of symptoms 
upon quality of life23 in case group subjects (mean score 
of 57.57) and controls (mean score of 52.67) before treat-
ment. However, another study found mild impact (mean 
score of 31.00) of symptoms upon the quality of life23 of 
patients with Ménière’s disease27.
After the intervention, controls showed reduced 
scores in the dizziness analog scale, although not accom-
panied by reduced DHI scores or larger stability limit areas. 
There are no papers in the literature describing the effects 
of BRUTM rehabilitation on patients with Ménière’s taking 
betahistine and submitted to dietary orientation.
Case group subjects improved from dizziness and 
reported better quality of life after the intervention, as in-
terpreted from the reduced scores in the dizziness analog 
scale and the difference of over 18 points in the DHI scores. 
Increases in the stability limit areas suggested improved 
ability to maintain body balance while moving without 
altering the support base. Similarly to our findings, patients 
with Ménière’s also reported improved quality of life after 
vestibular rehabilitation associated with psychotherapy28, 
after taking betahistine29, and after undergoing rehabilita-
tion on a BRUTM18. Improvements on the intensity of the 
dizzy spells were also observed18. Patients with Ménière’s 
disease submitted exclusively to treatment on a BRUTM 
failed to show significant increases on stability limits18, 
possibly due to the small size of the sample. No papers in 
the literature were found to describe the effects of BRUTM 
rehabilitation on patients with Ménière’s taking betahistine 
and submitted to dietary orientation in relation to DHI 
scores, the dizziness analog scale, and stability limit values.
After rehabilitation aided by virtual reality resour-
ces, patients in the case group performed differently from 
controls in terms of total DHI scores and physical, func-
tional, and emotional aspects. Differences were also seen 
in dizziness analog scale scores and stability limit areas, 
with case group individuals presenting more significant 
score reductions and, therefore, improvements from di-
zzy spells and in terms of quality of life when compared 
against controls. The significant increase in stability limit 
areas showed that case control subjects were better at 
moving and maintaining balance without altering the 
support base. No papers in the literature were found to 
compare the efficacy of BRUTM rehabilitation on patients 
with Ménière’s taking betahistine and submitted to dietary 
orientation against controls taking betahistine and submit-
ted to dietary orientation.
After the intervention, the performance of case 
group subjects was the same as found in controls in regards 
to CoP area values. However, case group individuals had 
smaller CoP areas when tested on a firm surface with eyes 
closed and on a compliant surface with eyes closed after 
the intervention, a finding that may be seen as a favorable 
effect of the rehabilitation program aided by virtual reality. 
Ten patients with Ménière’s disease submitted exclusively 
to BRUTM rehabilitation failed to show significant reductions 
on CoP areas in the ten sensory conditions in which they 
were tested18. Patients with central vestibular disorders13 
and elderly patients with instability and risk of falls17 sho-
wed reduced CoP areas in a firm surface with open eyes 
and during optokinetic stimulation to the right and to the 
left after vestibular rehabilitation with virtual reality.
After the intervention, the performance of the case 
group was similar to that of the control group in terms of 
oscillation rates, except for when subjects were tested on 
a compliant surface with eyes closed, which may be consi-
dered as a favorable effect provided by rehabilitation with 
virtual reality and of the increases seen during saccade and 
optokinetic stimulation in the vertical direction, possibly 
meaning that rehabilitation could not favorably interfere with 
the evolution of oscillation rates in these two conditions. As 
also seen in this study, patients with Ménière’s submitted to 
BRUTM rehabilitation had significant increases in oscillation 
rates in optokinetic stimulation in the vertical direction18. 
After vestibular rehabilitation with virtual reality and analysis 
of three sensory conditions (not the ten sensory conditions 
assessed with the BRUTM), reductions on oscillation rates 
when patients with central vestibular disorders13 and elderly 
subjects with instability and risk of falls17 were tested on a 
firm surface with open eyes and on optokinetic stimulation 
to the right and to the left.
No assessment instrument was able to consider all 
aspects involved in body balance. Today, body balance can 
be clinically verified through quality-of-life questionnaires, 
functional testing, and posturography. The procedures 
used to assess imbalance must be selected based on the 
goal of the assessment and the type of disorder observed30.
A quality-of-life questionnaire, the dizziness ana-
log scale, and a posturography device were picked to 
assess body balance before and after the intervention. 
The posturography equipment was also used in the 
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rehabilitation of patients with Ménière’s disease. In the 
context of assessment after intervention, case group sub-
jects may have had better outcomes than controls because 
they were more familiarized and trained on how to use 
the equipment. However, it should be pointed that only 
only two of the ten sensory test conditions - firm surface 
with eyes closed and compliant surface with eyes closed 
- yielded significant differences. Although posturography 
was not the ideal method to assess improvements after 
rehabilitation, we must point out that the apparent impro-
vements resulting from stimulation in the BRUTM agreed 
with improvements on DHI and dizziness analog scale sco-
res in the comparisons between case and control groups.
The visual, vestibular, and proprioceptive conflicts 
generated by virtual reality stimulation with the BRUTM, 
in combination with the administration of betahistine and 
nutritional orientation, contributed significantly to the 
attainment of improvements in dizziness, quality of life, 
and postural control in patients with Ménière’s disease.
Further studies on the use of rehabilitation aided 
by virtual reality in patients with Ménière’s disease are 
required to verify how effectively other body balance 
functional tests can be used in the short and long terms, 
particularly due to the fluctuating nature of this disease.
CONCLUSION
Body balance rehabilitation with virtual reality 
stimuli effectively improved symptoms of dizziness, qua-
lity of life, and stability limits of patients with Ménière’s 
disease.
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